Stocks · Health care · Pharmaceutical Preparations

Acrivon Therapeutics, Inc.

ACRV Clue Score43
United States Fiscal year ends December CIK 0001781174
1.91
+2.14%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
1.91 on 9 Oct 2026
3 2 1 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $1.77 14 Oct 2025 $1.74 15 Oct 2025 $1.89 16 Oct 2025 $1.87 17 Oct 2025 $1.81 20 Oct 2025 $1.92 21 Oct 2025 $2.04 22 Oct 2025 $1.99 23 Oct 2025 $2.00 24 Oct 2025 $2.07 27 Oct 2025 $2.09 28 Oct 2025 $1.98 29 Oct 2025 $1.89 30 Oct 2025 $1.94 31 Oct 2025 $1.99 3 Nov 2025 $2.33 4 Nov 2025 $2.15 5 Nov 2025 $2.03 6 Nov 2025 $2.00 7 Nov 2025 $1.88 10 Nov 2025 $2.03 11 Nov 2025 $2.07 12 Nov 2025 $2.28 13 Nov 2025 $2.07 14 Nov 2025 $2.24 17 Nov 2025 $2.38 18 Nov 2025 $2.43 19 Nov 2025 $2.36 20 Nov 2025 $2.26 21 Nov 2025 $2.30 24 Nov 2025 $2.36 25 Nov 2025 $2.32 26 Nov 2025 $2.36 28 Nov 2025 $2.36 1 Dec 2025 $2.42 2 Dec 2025 $2.20 3 Dec 2025 $2.28 4 Dec 2025 $2.41 5 Dec 2025 $2.37 8 Dec 2025 $2.52 9 Dec 2025 $2.49 10 Dec 2025 $2.62 11 Dec 2025 $2.61 12 Dec 2025 $2.53 15 Dec 2025 $2.57 16 Dec 2025 $2.42 17 Dec 2025 $2.31 18 Dec 2025 $2.26 19 Dec 2025 $2.16 22 Dec 2025 $2.32 23 Dec 2025 $2.32 24 Dec 2025 $2.39 26 Dec 2025 $2.44 29 Dec 2025 $2.36 30 Dec 2025 $2.44 31 Dec 2025 $2.41 2 Jan 2026 $2.46 5 Jan 2026 $2.29 6 Jan 2026 $3.01 7 Jan 2026 $2.95 8 Jan 2026 $1.93 9 Jan 2026 $1.75 12 Jan 2026 $1.63 13 Jan 2026 $1.70 14 Jan 2026 $1.83 15 Jan 2026 $1.87 16 Jan 2026 $1.98 20 Jan 2026 $1.96 21 Jan 2026 $2.09 22 Jan 2026 $2.03 23 Jan 2026 $2.05 26 Jan 2026 $1.94 27 Jan 2026 $1.98 28 Jan 2026 $1.89 29 Jan 2026 $1.88 30 Jan 2026 $1.79 2 Feb 2026 $1.81 3 Feb 2026 $1.76 4 Feb 2026 $1.69 5 Feb 2026 $1.60 6 Feb 2026 $1.67 9 Feb 2026 $1.62 10 Feb 2026 $1.56 11 Feb 2026 $1.50 12 Feb 2026 $1.58 13 Feb 2026 $1.63 17 Feb 2026 $1.60 18 Feb 2026 $1.59 19 Feb 2026 $1.58 20 Feb 2026 $1.53 23 Feb 2026 $1.50 24 Feb 2026 $1.50 25 Feb 2026 $1.68 26 Feb 2026 $1.84 27 Feb 2026 $1.51 2 Mar 2026 $1.53 3 Mar 2026 $1.67 4 Mar 2026 $1.69 5 Mar 2026 $1.60 6 Mar 2026 $1.55 9 Mar 2026 $1.60 10 Mar 2026 $1.66 11 Mar 2026 $1.63 12 Mar 2026 $1.61 13 Mar 2026 $1.62 16 Mar 2026 $1.70 17 Mar 2026 $1.66 18 Mar 2026 $1.64 19 Mar 2026 $1.70 20 Mar 2026 $1.66 23 Mar 2026 $1.60 24 Mar 2026 $1.58 25 Mar 2026 $1.52 26 Mar 2026 $1.42 27 Mar 2026 $1.33 30 Mar 2026 $1.29 31 Mar 2026 $1.39 1 Apr 2026 $1.46 2 Apr 2026 $1.52 6 Apr 2026 $1.57 7 Apr 2026 $1.47 8 Apr 2026 $1.53 9 Apr 2026 $1.55 10 Apr 2026 $1.56 13 Apr 2026 $1.61 14 Apr 2026 $1.64 15 Apr 2026 $1.67 16 Apr 2026 $1.67 17 Apr 2026 $1.78 20 Apr 2026 $1.86 21 Apr 2026 $1.76 22 Apr 2026 $1.97 23 Apr 2026 $1.89 24 Apr 2026 $1.91 27 Apr 2026 $1.88 28 Apr 2026 $1.90 29 Apr 2026 $1.81 30 Apr 2026 $1.85 1 May 2026 $2.09 4 May 2026 $2.17 5 May 2026 $2.08 6 May 2026 $2.09 7 May 2026 $2.03 8 May 2026 $1.98 11 May 2026 $1.91 12 May 2026 $1.89 13 May 2026 $1.92 14 May 2026 $1.92 15 May 2026 $1.77 18 May 2026 $1.65 19 May 2026 $1.60 20 May 2026 $1.76 21 May 2026 $1.79 22 May 2026 $1.75 26 May 2026 $1.67 27 May 2026 $1.66 28 May 2026 $1.63 29 May 2026 $1.60 1 Jun 2026 $1.56 2 Jun 2026 $1.57 3 Jun 2026 $1.51 4 Jun 2026 $1.55 5 Jun 2026 $1.43 8 Jun 2026 $1.41 9 Jun 2026 $1.42 10 Jun 2026 $1.38 11 Jun 2026 $1.44 12 Jun 2026 $1.48 15 Jun 2026 $1.52 16 Jun 2026 $1.49 17 Jun 2026 $1.52 18 Jun 2026 $1.57 22 Jun 2026 $1.58 23 Jun 2026 $1.63 24 Jun 2026 $1.62 25 Jun 2026 $1.58 26 Jun 2026 $1.68 29 Jun 2026 $1.78 30 Jun 2026 $1.78 1 Jul 2026 $1.73 2 Jul 2026 $1.72 6 Jul 2026 $1.78 7 Jul 2026 $1.86 8 Jul 2026 $2.04 9 Jul 2026 $2.05 10 Jul 2026 $1.96 13 Jul 2026 $1.98 14 Jul 2026 $2.13 15 Jul 2026 $1.92 16 Jul 2026 $1.75 17 Jul 2026 $1.75 20 Jul 2026 $1.74 21 Jul 2026 $1.75 22 Jul 2026 $1.68 23 Jul 2026 $1.67 24 Jul 2026 $1.60 27 Jul 2026 $1.56 28 Jul 2026 $1.54 29 Jul 2026 $1.43 30 Jul 2026 $1.52 31 Jul 2026 $1.50 3 Aug 2026 $1.56 4 Aug 2026 $1.56 5 Aug 2026 $1.64 6 Aug 2026 $1.69 7 Aug 2026 $1.73 10 Aug 2026 $1.74 11 Aug 2026 $1.73 12 Aug 2026 $1.72 13 Aug 2026 $1.85 14 Aug 2026 $1.95 17 Aug 2026 $2.05 18 Aug 2026 $2.05 19 Aug 2026 $2.39 20 Aug 2026 $2.20 21 Aug 2026 $2.21 24 Aug 2026 $2.20 25 Aug 2026 $2.18 26 Aug 2026 $2.08 27 Aug 2026 $2.15 28 Aug 2026 $2.06 31 Aug 2026 $2.09 1 Sep 2026 $2.07 2 Sep 2026 $2.15 3 Sep 2026 $2.06 4 Sep 2026 $2.13 8 Sep 2026 $2.10 9 Sep 2026 $1.99 10 Sep 2026 $2.04 11 Sep 2026 $2.00 14 Sep 2026 $1.96 15 Sep 2026 $1.83 16 Sep 2026 $1.70 17 Sep 2026 $1.70 18 Sep 2026 $1.85 21 Sep 2026 $2.01 22 Sep 2026 $2.15 23 Sep 2026 $2.06 24 Sep 2026 $2.12 25 Sep 2026 $2.10 28 Sep 2026 $2.06 29 Sep 2026 $2.08 30 Sep 2026 $2.05 1 Oct 2026 $2.01 2 Oct 2026 $1.99 5 Oct 2026 $1.98 6 Oct 2026 $1.86 7 Oct 2026 $1.88 8 Oct 2026 $1.87 9 Oct 2026 $1.91 Devroe Eric Chief Operating Officer Bought $17.22K 13 Jan 2026 · at $1.72 · 15.3% of stake Levy Adam D. Chief Financial Officer Bought $15.00K 14 Jan 2026 · at $1.70 · 72.7% of stake Blume-Jensen Peter President and CEO Bought $82.12K 14 Jan 2026 · at $1.68 · 2.4% of stake Miller Mary Chief Legal Officer Sold at will $1.01K 21 Jul 2026 · at $1.76 · 0.7% of stake Levy Adam D. Chief Financial Officer Sold at will $1.79K 4 Aug 2026 · at $1.57 · 1.7% of stake Peterson Katharine Chief Accounting Officer Sold at will $203.01 18 Aug 2026 · at $2.01 · 0.6% of stake Miller Mary Chief Legal Officer Sold at will $371.85 18 Aug 2026 · at $2.01 · 0.2% of stake Gamelin Erick Chief Development Officer Sold at will $804.00 18 Aug 2026 · at $2.01 · 0.8% of stake Blume-Jensen Peter President and CEO Sold at will $972.84 18 Aug 2026 · at $2.01 · 0.1% of stake Devroe Eric Chief Operating Officer Sold at will $1.21K 18 Aug 2026 · at $2.01 · 0.4% of stake Blume-Jensen Peter President and CEO Sold at will $2.47K 18 Aug 2026 · at $2.01 · 0.1% of stake Blume-Jensen Peter President and CEO Sold at will $30.97K 25 Aug 2026 · at $2.21 · 0.6% of stake Miller Mary Chief Legal Officer Sold at will $585.06 5 Oct 2026 · at $1.99 · 0.4% of stake
3 buys10 sales at will0 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Net income
$77.91M
Free cash flow
$65.33M
Return on equity
-69.2%
Return on capital
-59.1%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -16M FY21 Fiscal year 2021 Revenue $0.00 Net income $16.24M Margin n/a 0K -31M FY22 Fiscal year 2022 Revenue $0.00 Net income $31.17M Margin n/a 0K -60M FY23 Fiscal year 2023 Revenue $0.00 Net income $60.39M Margin n/a 0K -81M FY24 Fiscal year 2024 Revenue $0.00 Net income $80.56M Margin n/a 0K -78M FY25 Fiscal year 2025 Revenue $0.00 Net income $77.91M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
5 Oct 2026 Miller Mary
Chief Legal Officer
Sold at will $585.06 0.4%
25 Aug 2026 Blume-Jensen Peter
President and CEO
Sold at will $30.97K 0.6%
18 Aug 2026 Blume-Jensen Peter
President and CEO
Sold at will $2.47K 0.1%
18 Aug 2026 Devroe Eric
Chief Operating Officer
Sold at will $1.21K 0.4%
18 Aug 2026 Blume-Jensen Peter
President and CEO
Sold at will $972.84 0.1%
18 Aug 2026 Gamelin Erick
Chief Development Officer
Sold at will $804.00 0.8%